Breaking News

Genmab (GMAB)

Symbol	Exchange	Currency
GMAB	Copenhagen	DKK	Real-time
GMABc	BATS Europe	DKK	Delayed
GMAB	NASDAQ	USD	Real-time
0MGB	London	DKK	Real-time
GE91y	TradeGate	EUR	Delayed
GMAB	Vienna	EUR	Real-time

Add to/Remove from Watchlist Add to Watchlist

1,339.0 +19.0 +1.44%

- Closed. Currency in DKK

Type: Equity

Market: Denmark

ISIN: DK0010272202

S/N: 64120391

Volume: 127,436
Bid/Ask: 0.0 / 0.0
Day's Range: 1,332.0 - 1,353.0

General
Chart
- Streaming Chart
- Interactive Chart
News & Analysis
- News
- Analysis & Opinion
Financials
Technical
Forum

Genmab Company Profile

Get an in-depth profile of Genmab, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryBiotechnology & Medical Research

SectorHealthcare

Employees

2635

Equity Type

ORD

Genmab A/S, a biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark. The company markets EPKINLY and TEPKINLY for adult patients with relapsed or refractory (R/R) diffuse large b-cell lymphoma (DLBCL), large Bcell lymphoma, and follicular lymphoma (FL); and Tivdak for adult patients with recurrent/metastatic cervical cancer with disease progression on or after chemotherapy. It is also developing Epcoritamab for R/R DLBCL and FL, first line DLBCL and FL, B-cell non-Hodgkin lymphoma, R/R chronic lymphocytic leukemia and Richter’s syndrome, and aggressive mature B-cell neoplasms in pediatric patients; tisotumab vedotin for solid tumors; Acasunlimab for solid tumors and non-small cell lung cancer (NSCLC); Rinatabart Sesutecan for platinum resistant ovarian cancer and solid tumors; GEN1042, GEN1059, GEN1055, and GEN1057 for solid tumors; GEN3014 for hematologic malignancies; GEN1160 for advanced solid and liquid tumors; and GEN1107 and GEN1286 for advanced solid tumors. In addition, the company offers DARZALEX/DARZALEX FASPRO for multiple myeloma (MM) and light-chain Amyloidosis; RYBREVANT for NSCLC; TECVAYLI and TALVEY for R/R MM; Kesimpta for Relapsing multiple sclerosis; and TEPEZZA for thyroid eye disease. Further, it is developing Amivantamab for recurrent/metastatic head and neck cancer, and advanced or metastatic colorectal cancer; Amlenetug for multiple system atrophy; Inclacumab for vaso-occulsive crises in sickle cell diseases; and Mim8 for hemophilia A. The company has a collaboration agreement with AbbVie Inc., Pfizer Inc., BioNTech SE, Johnson & Johnson, Novartis International AG, Medarex, Inc., ADC Therapeutics SA, Bristol Myers Squibb Corporation, Lundbeck A/S, Amgen Inc., Immatics, Novo Nordisk A/S, CureVac AG, and argenx. Genmab A/S was incorporated in 1998 and is headquartered in Copenhagen, Denmark.

Contact Information

Address Carl Jacobsens Vej 30 Valby
Copenhagen, 2500
Denmark

Phone 45 70 20 27 28

Fax -

Web www.genmab.com

Top Executives

Name	Age	Since	Title
Anders Gersel Pedersen	73	2003	Non-Independent Director
Deirdre P. Connelly	63	2017	Independent Chairman of the Board
Paolo Paoletti	73	2015	Independent Director
Pernille Erenbjerg	57	2015	Independent Deputy Chairman
Rolf Karl-Heinz Hoffmann	65	2016	Independent Director
Elizabeth G. O'Farrell	59	2022	Independent Director
Martin Schultz	49	2022	Senior Director of Clinical Operations & Non-Independent Director
Mijke Zachariasse	51	2019	Senior Director, Head of Antibody Research Materials & Non-Independent Director
Takahiro Hamatani	50	2022	Senior Director of Finance Japan & Non-Independent Director

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.
Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read Investing.com's comments guidelines and agree to the terms described.

I Agree

GMAB Comments

Write your thoughts about Genmab

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

Mark Marriott Oct 27, 2021 7:48AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

this stock worths buying for the long term?

5 0

Report

TheNote Jul 26, 2021 11:40AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Target 3620 .. medium/long.Daily chart: https://invst.ly/vjgx1 Weekly chart: https://invst.ly/vjgxu

1 0

Report

TheNote Jul 26, 2021 11:33AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Cup with handle - emminent !!!https://www.proinvestor.com/boards/95471Translate from that site (from danish) into english.

0 0

Report

JohnJenga Mar 17, 2021 7:29AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

NBI might roll over. Risky now

0 0

Report

JohnJenga Mar 07, 2021 1:15PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

1992 indicative price vs 1901 close dk and 1970 close us

0 0

Report

JohnJenga Mar 07, 2021 1:15PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

2200 this week possible, imo

0 0

Report

JohnJenga Mar 04, 2021 5:31AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

nice correction - but have more or less only removed dec7jan baboon buys

0 0

Report

Martin Lynge Mar 04, 2021 5:31AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

You mean since June last year.. .. Giant sell out...

0 0

Report

Martin Lynge Jun 27, 2019 2:52PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

US 1st line approval this evening... 1200+ tomorrow?

2 0

Report

Michael Almskov Jun 27, 2019 2:10PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

https://oasm.finanstilsynet.dk/dk/vismeddelelse.aspx?aid=f7f1738b-beb1-47b2-a9dc-ab402ccd42e9

3 0

Report

Michael Almskov Jun 19, 2019 3:15PM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Blackrock now owns 5% of the shares in genmab

4 0

Report

Martin Lynge Feb 25, 2019 9:08AM ET

Follow this post

Unfollow this post

Save

Saved. See Saved Items.

This comment has already been saved in your Saved Items

Block User

Interesting to see, if we go beyond 1120 this time...

1 0

Report

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="200774773">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="200774773" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow js-option blockUser js-block-option" data-comment-id="{commentID}"  data-user-id="200774773" data-reg_ep="block user comments">
			<a href="javascript:void(0);">
				<span class="blockIcon middle"></span>Block User			</a>
		</div>
				<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="200774773">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="200774773">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="200774773" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d1-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d1-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="200774773">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

US 30	42,661.4	-130.5	-0.31%
US 500	5,939.0	-24.6	-0.41%
Dow Jones	42,677.24	-114.83	-0.27%
S&P 500	5,940.46	-23.14	-0.39%
Nasdaq	19,142.71	-72.75	-0.38%
S&P 500 VIX	18.10	-0.04	-0.22%
Dollar Index	99.887	-0.401	-0.40%

Crude Oil WTI	62.33	+0.19	+0.31%
Brent Oil	65.68	+0.14	+0.21%
Natural Gas	3.404	+0.291	+9.35%
Gold	3,293.84	+60.34	+1.87%
Silver	33.265	+0.758	+2.33%
Copper	4.6783	+0.0078	+0.17%
US Soybeans	1,054.25	+4.25	+0.40%

U.S. 10Y	4.484	+0.009	+0.20%
U.S. 30Y	4.969	+0.028	+0.57%
U.S. 5Y	4.072	-0.009	-0.22%
U.S. 3M	4.364	+0.008	+0.18%
US 10Y T-Note	110.17	+0.03	+0.03%
Euro Bund	130.29	-0.25	-0.19%
10-2 Yield Spread	31.32	+4.15	+15.27%

Apple	206.86	-1.92	-0.92%
NVIDIA	134.38	-1.19	-0.88%
Alphabet A	164.00	-2.54	-1.53%
Tesla	343.76	+1.67	+0.49%
Amazon.com	204.07	-2.09	-1.01%
Netflix	1,192.02	+0.38	+0.03%
Meta Platforms	637.24	-3.19	-0.50%

Recent Quotes

	Name	Price	Chg.	Chg. %
	GMAB	1,339.0	+19.0	+1.44%

Market Movers

Name	Last	Chg. %	Vol.
NVDA	134.38	-0.88%	155.07M
TSLA	343.76	+0.49%	128.39M
PLTR	125.59	-0.59%	59.96M
GOOGL	164.00	-1.53%	45.82M
UNH	321.58	+1.80%	40.91M
AAPL	206.86	-0.92%	39.63M
AMZN	204.07	-1.01%	28.69M

Name	Last	Chg. %	Vol.
MRNA	28.00	+6.10%	35.39M
DLTR	90.62	+4.63%	3.93M
DG	102.20	+4.09%	6.76M
HUM	255.31	+3.22%	1.85M
REGN	614.79	+3.21%	1.10M
D	58.00	+3.20%	10.83M
ES	65.55	+3.18%	3.63M

Name	Last	Chg. %	Vol.
FICO	2,027.00	-8.11%	564.21K
SMCI	42.77	-4.51%	42.60M
AES	11.24	-4.01%	25.87M
NCLH	18.17	-3.91%	14.85M
ABNB	132.13	-3.27%	6.59M
LVS	40.94	-3.25%	5.72M
UAL	76.33	-2.91%	8.06M

Webinars

From Beginner to Pro: Navigating Your InvestingPro Subscription Wednesday, May 21, 2025 | 10:00AM EDT